Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2017 Jun 23;17:446. doi: 10.1186/s12879-017-2545-z

Erratum to: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in mid-Norway: a prospective observational study

Arne Mehl 1,2,3,, Bjørn Olav Åsvold 3,4,5, Angela Kümmel 6, Stian Lydersen 7, Julie Paulsen 1,3,8, Ingvild Haugan 9, Erik Solligård 3,10,11, Jan Kristian Damås 3,8,12, Stig Harthug 13,14, Tom-Harald Edna 2,15
PMCID: PMC5481901  PMID: 28645322

Erratum

After publication of the original article [1] the authors found the following errors had occurred:

  1. The y-axis of Fig. 3 has been incorrectly titled ‘Percent’. The correct title is ‘Number of episodes’. (Fig. 3).

  • 2.

    The legend of Fig. 3 did not contain correct information on the figure.

Fig. 3.

Fig. 3

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility

The legend on Fig. 3 was originally labelled:

Microbes non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. (Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail) ANS, acquired non-susceptibility; INS, inherent non-susceptibility

However, this has been corrected to:

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility (Fig. 3)

A corrected version of the figure is included in this Erratum:

Footnotes

The online version of the original article can be found under doi:10.1186/s12879-017-2210-6

Reference

  • 1.Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, Solligård E, Damås JK, Harthug S, Edna T-H. BMC Infectious Diseases. 2017;17:116. doi: 10.1186/s12879-017-2210-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES